Two types of molecular tests have been established to assess the deficiency of DNA mismatch repair (MMR) system: microsatellite instability (MSI) and immunohistochemical (IHC) analysis. We have developed a reliable method to analyze the MSI status by next-generation sequencing (NGS) based on read count distribution. A total of 91 patients with primary colorectal cancer were recruited. These patients included 54 cases with the loss of expression of any MMR protein in IHC suggesting deficient MMR (dMMR), and 37 cases of colorectal cancer with staining of all four MMR proteins in IHC, suggesting proficient MMR (pMMR) in postoperative sample. DNA was extracted from paired tumor-normal tissue for MSI detection by both ColonCore NGS panel and PCR. The sequencing data from NGS panel was processed using various MSI detection pipelines for a comparison with the ColonCore panel.
The DNA mismatch repair (MMR) function detection is applied to not only the initial molecular screening for Lynch syndrome, a major type of hereditary colorectal cancer (CRC) characterized by germline mutations in MMR genes, but also the selection of suitable patients for immunotherapy, since anti-programmed death-1 (anti-PD-1) therapies have achieved significant success in various MSI-H/dMMR cancers with the fact that Pembrolizumab (anti-PD-1 therapy) is recently approved by Food and Drug Administration for the treatment of M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 6 patients with unresectable or metastatic solid tumors who are referred to be MSI-H or dMMR. 2, 3 Before the era of massively parallel DNA sequencing, MSI is detected by PCR-based methods at specific microsatellite markers and CRCs can be classified into MSI-high (MSI-H), MSI-low (MSI-L), and microsatellite stable (MSS) according to the proportion of unstable markers. 4, 5 As next-generation sequencing (NGS) is increasingly applied to detect tumor gene mutations, combining MSI status and mutation detection into the same sequencing process would highly decrease the demand of tissue samples and increase the efficiency of tests.
Currently, two types of methods have been proposed for the detection of MSI status by NGS.
The first type tries to postulate MSI status from mutation burden, which is usually detected by whole-exome sequencing, and demonstrates a significant correlation between total mutation burden and MSI status. [6] [7] [8] The other type of methods directly measure the level of microsatellite instability by the read count distribution of a selected set of loci with different repeat lengths. Current approaches based on read count distribution include MSIsensor and mSINGS. 9, 10 MSIsensor requires paired tumor and normal samples, and compares the histogram of read counts covering different repeat lengths of the loci using standard
A locus is considered length-instable if the adjusted P-value is less than a pre-determined threshold. 
Materials and Methods
With the approval of Ethics Committee of the Second Affiliated Hospital of Zhejiang Table S1 ). The MSI phenotype detection method of MSI-ColonCore was a read-count-distribution-based approach. It utilized the coverage ratio of a specific set of repeat lengths as the main characteristic of each microsatellite locus, and categorized a locus as unstable if the coverage ratio was less than a given threshold. The MSI status of a sample was determined by the percentage of unstable loci in the given sample. The details of the method are described below. The raw reads were deposited in NCBI Sequence Read Archive (SRA) (https://trace.ncbi.nlm.nih.gov/Traces/sra/) accession number SRP119517.
Data preprocessing
To determine the MSI status, the microsatellite loci were firsst scanned from the reference genome, and the number of reads aligned to the loci of different repeat lengths was calculated in a training set of samples of known MSI status. The scanned loci were restricted to mononucleotide repeats, as those were reported as the most sensitive and specific for MSI detection. 10 Sequencing reads were aligned by BWA (v0.7.10) against the reference genome (hg19/GRCh37). Reads aligned to the loci at every possible repeat length were counted respectively using the same strategy as proposed by MSIsensor (9) . To obtain the read counts
with highest specificity and also allow for sequencing errors, especially for loci with low coverage, two versions of read count statistics were generated by applying perfect match restriction and allowing 1bp-mismatch, respectively, in the alignment.
Loci characterization and baseline construction
Among the loci scanned from the reference genome, those showed high consistency between the stability of their repeat lengths and the MSI status of their corresponding sample were selected as marker microsatellite loci. In microsatellite stable samples, the length of homopolymers in the marker microsatellite loci were relatively stable. In other words, reads were aligned to only a few types of repeat-lengths. For each microsatellite locus, the specific repeat-length covered by the largest amount of reads was called peak length, and the read count was called peak count. Repeat lengths covered by no less than 75% peak count were were calculated afterwards, and the threshold of SD] 3 [mean × − was set as the lower limit for a length-stable locus.
A Locus with coverage ratio less than the threshold was determined as a length-instable one.
The final set of marker microsatellite loci were then selected using the training sample set with the following criteria: length-instable in more than 75% MSI samples, length-stable in more than 75% MSS samples, and has an average Spearman correlation higher than 0.8 between the ratio of reads covering each type of repeat length of the loci of each pair of normal samples.
MSI status determination for samples
After the selection of marker microsatellite loci and the establishment of the ratio reference, the MSI status of a tumor sample could be determined based on the percentage of length-instable loci, without a paired normal control. For each marker locus, the read count histogram was constructed and the coverage ratio of the reference length set was calculated and compared to the reference threshold. A locus with a coverage ratio less than
of the reference ratio was determined as a length-instable locus. A tumor sample is considered MSI-H if more than 40% of the marker loci are length-instable, MSS if the percentage of length-instable loci were less than 15%, or MSI-L for if the percentage is between 15% to 40%. (1)
Performance evaluation index for the NGS-based approaches
where TP, TN, FP, and FN denoted the true positive, true negative, false positive, and false negative, respectively. Twenty-two marker microsatellite loci were selected as the final set according to criteria described in the Materials and Methods. The list of the marker loci and the baseline statistics are listed in Table 1 .
MSI detection by PCR

Validation of MSI-ColonCore MSI method against conventional PCR-MSI
MSI-ColonCore achieved 97.9% sensitivity (47/48) and 100% specificity (37/37) for the detection of MSI when MSI-PCR testing performed as the gold standard, with one PCR M A N U S C R I P T
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MSI-H sample labeled as MSI-L ( Table 2) .
Correlation between MSI and IHC status
According to MSI-ColonCore, all of 37 IHC pMMR cases were identified as MSS, whereas 47 of 54 IHC dMMR cases were MSI-H, with the remaining seven interpreted as MSS/MSI-L.
In MSI-PCR testing, the results were almost the same as MSI-ColonCore, except that the case interpreted as MSI-L in MSI-ColonCore turned out to be MSI-H in MSI-PCR, and one considered as MSI-L in MSI-ColonCore turned to be MSS in MSI-PCR. Therefore, the concordance rate was 92.3% between MSI-ColonCore and IHC testing, and 93.4% between MSI-PCR and IHC testing. (Table 2 )
Comparison of MSI status detection ability among different NGS-based methods
Here, we compared the performance of our approach to that of two previously published read-count-distribution-based methods: MSIsensor(v0. Table 3 . ColonCore panel achieved best performance according to Table 3 . In addition, the independency of paired normal sample of the algorithm makes it more practical in clinical applications.
ColonCore: a more robust MSI status detection method comparing to mSINGS
As the percentage of length-instable loci is the key index to distinguish between MSI statuses for a sample, the distribution of the percentage in MSS and MSI-H samples were compared between the three methods. The percentages were most distinguished by ColonCore panel, which demonstrated its robustness in MSI status detection (Figure 1 ).
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Mutation burden comparison between MSI-H and MSS samples
The high correlation of MSI status and mutation burden has been demonstrated by recent reports benefiting from whole-exon sequencing. The mutation burden per Mb of MSI-H and MSS samples reported by MSI-ColonCore was presented as two violin plots (Figure 2 ).
Although MSI-H samples tended to have higher mutation burden, the two types of samples were not as highly distinguished as reported.
Discussion
The deficiency of DNA mismatch repair system can be assessed through approaches at two With the development of NGS technology, NGS-based MSI analysis has been increasingly adopted for two major advantages. First, NGS sequencing panels, when properly designed, can capture the mutation spectrum and MSI status in CRC patients simultaneously, reducing the amount of tissue sample required and simplifying the testing process. Second, after NGS-based MSI analysis properly constructing baseline reference set, like in the ColonCore panel, it eliminates the need of normal control samples, which will benefit patients without surgery, especially for most metastatic cancers.
As described earlier, NGS-based MSI analyses fall into two categories: the mutation burden approach and the read count distribution approach. The application of the mutation burden approach is limited in clinical practice, for the need of large and costly sequencing panels of hundreds of genes or even whole exome analysis, as mutation burden calculated from small panels tends to deviate from the real value. For an example, in the present study, mutation burden calculated from our panel of 36 hotspot genes is obviously over-estimated than those from large panels, and due to the small number of genes, even adjusted mutation burdens will Besides, previous studies had discussed the power of NGS in clinical practice 22, 23 .
Furthermore, the performance of MSI-ColonCore is comparable with golden standard PCR-MSI. Therefore, the NGS-based ColonCore panel is cost-effective and promising in clinical practice.
Our study is to some extent limited by the relatively small number of cases, due to the only 15%
CRCs driven by MMR deficiency. 24 More cases will be recruited to further validate our findings, and the capability of MSI-ColonCore will also be tested in other types of cancers with high MSI, such as endometrial cancer and gastric cancer.
In summary, MSI-ColonCore can detect MSI accurately and more robustly compared with current NGS methods based on read count distribution. 
